Log In
Print
BCIQ
Print
Print this Print this
 

Sebivo, Tyzeka, telbivudine (LdT) (LDT600)

  Manage Alerts
Collapse Summary General Information
Company Idenix Pharmaceuticals Inc.
DescriptionNucleoside analog
Molecular Target Viral polymerase
Mechanism of ActionDNA polymerase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat chronic hepatitis B virus (HBV) infection
Regulatory Designation

Partner

Novartis AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today